Effects of dietary fatty acids and cholesterol excess on liver injury: A lipidomic approach

• Main Authors: Gaetano Serviddio, Francesco Bellanti, Rosanna Villani, Rosanna Tamborra, Chiara Zerbinati, Maria Blonda, Marco Ciacciarelli, Giuseppe Poli, Gianluigi Vendemiale, Luigi Iuliano
• Format: Article
• Language: English
• Published: Elsevier 2016-10-01
• Series: Redox Biology
• Subjects: Oxysterols; Non-alcoholic fatty liver disease; Cholesterol excess; Fatty acids
• Online Access: http://www.sciencedirect.com/science/article/pii/S2213231716300660

Lipid accumulation is the hallmark of Non-alcoholic Fatty Liver Disease (NAFLD) and has been suggested to play a role in promoting fatty liver inflammation. Previous findings indicate that during oxidative stress conditions excess cholesterol autoxidizes to oxysterols. To date, the role of oxysterols and their potential interaction with fatty acids accumulation in NASH pathogenesis remains little investigated. We used the nutritional model of high fatty acids (HFA), high cholesterol (HCh) or high fat and high cholesterol (HFA+FCh) diets and explored by a lipidomic approach, the blood and liver distribution of fatty acids and oxysterols in response to dietary manipulation. We observed that HFA or HCh diets induced fatty liver without inflammation, which was otherwise observed only after supplementation of HFA+HCh. Very interestingly, the combination model was associated with a specific oxysterol fingerprint. The present work provides a complete analysis of the change in lipids and oxysterols profile induced by different lipid dietary model and their association with histological alteration of the liver. This study allows the generation of interesting hypotheses on the role of interaction of lipid and cholesterol metabolites in the liver injury during NAFLD development and progression. Moreover, the changes in the concentration and quality of oxysterols induced by a combination diet suggest a novel potential pathogenic mechanism in the progression from simple steatosis to steatohepatitis.